Skip to main content
Have a personal or library account? Click to login
Childhood Osteoporosis and Presentation of Two Cases with Osteogenesis Imperfecta Type V / Osteoporoza V Otroški Dobi in Predstavitev Dveh Bolnikov Z Osteogenesis Imperfecta Tipa V Cover

Childhood Osteoporosis and Presentation of Two Cases with Osteogenesis Imperfecta Type V / Osteoporoza V Otroški Dobi in Predstavitev Dveh Bolnikov Z Osteogenesis Imperfecta Tipa V

Slovenian Journal of Public Health
Volume 54 (2015): Issue 2 (June 2015)
By: ,  ,  ,  ,  ,  ,   and    
Open Access
|Mar 2015
References

References

  1. 1. Bachrach LK, Hastie T, Wnag M-C, Narasimhan B, Marcus R. Bone mineral acquisition in healthy Asian, Hispanic, Black, and Caucasian youth: a longitudinal study. J Clin Endocrinol Metab 1999; 84: 4702-12.
    Open DOISearch in Google Scholar
  2. 2. Manolagas SC, Jilka RL. Bone marrow, cytokines, and bone remodeling. N Engl J Med 1995; 332: 305-11.
    Open DOISearch in Google Scholar
  3. 3. Blake GM, Naeem M, Boutros M. Comparison of effective dose to children and adults from dual X-ray absorptiometry examinations. Bone 2006; 38: 935-42.
    Open DOISearch in Google Scholar
  4. 4. World Health Organization. WHO scientific group assessement of the osteoporosis at the primary care level. Geneva: WHO, 2004.
    Search in Google Scholar
  5. 5. Bachrach L, Sills I. Clinical report-bone densitometry in children and adolescents. Pediatrics 2011; 127: 189-94.
    Open DOISearch in Google Scholar
  6. 6. Zemel BS, Leonard MB, Kelly A, Lappe JM, Gilsanz V, Oberfield S. et al. Height adjustment in assessing dual energy X-ray absorptiometry measurements of bone mass and density in children. J Clin Endocrinol Metab 2010; 95: 1265-73.
    Open DOISearch in Google Scholar
  7. 7. Landin LA. Epidemiology of children’s fractures. J Pediatr Orthop B 1997; 6: 79-83.
    Open DOISearch in Google Scholar
  8. 8. Goulding A, Jones IE, Taylor RW, Manning PJ, Williams SM. More broken bones: a 4-year double cohort study of young girls with and without distal forearm fractures. J Bone Miner Res 2000; 15: 2011-8.
    Open DOISearch in Google Scholar
  9. 9. Shaw NJ. Osteoporosis in paediatrics. Arch Dis Child Educ Pract Ed 2007; 92: 169-75
    Open DOISearch in Google Scholar
  10. 10. Warman ML, Cormier-Daire V, Hall C, Krakow D, Lachman R, LeMerrer M. et al. Nosology and classification of genetic skeletal disorders: 2010 revision. Am J Med Genet A 2011; 155A: 943-68.
    Open DOISearch in Google Scholar
  11. 11. Valadares ER, Carneiro TB, Santos PM, Oliveira AC, Zabel B. What is new in genetics and osteogenesis imperfecta classification? J Pediatr (Rio J) 2014; 90: 536-41.
    Search in Google Scholar
  12. 12. Marini JC, Reich A, Smith SM. Osteogenesis imperfecta due to mutations in non-collagenous genes: lessons in the biology of bone formation. Curr Opin Pediatr 2014; 26: 500-7.
    Open DOISearch in Google Scholar
  13. 13. van Dijk FS, Zillikens MC, Micha D, Riessland M, Marcelis CL, de Die- Smulders CE. et al. PLS3 mutations in X-linked osteoporosis with fractures. N Engl J Med 2013; 369: 1529-36.
    Open DOISearch in Google Scholar
  14. 14. Glorieux F, Rauch F, Plotkin H, Ward L, Travers R, Roughley P. et al. Type V osteogenesis imperfecta: a new form of brittle bone disease. J Bone Miner Res 2000; 15: 1650-8.
    Open DOISearch in Google Scholar
  15. 15. Rauch F, Glorieux F. Osteogenesis imperfecta. Lancet 2004; 363: 1377-85.
    Open DOISearch in Google Scholar
  16. 16. Cheung MS, Glorieux FH, Rauch F. Natural history of hyperplastic callus formation in osteogenesis imperfecta type V. J Bone Miner Res 2007; 22: 1181-6.
    Open DOISearch in Google Scholar
  17. 17. Vieira RL, Amaral DT, Jesus-Garcia FR, Saraiva G, Fernandes AR, Resnick D. Hyperplastic callus formation in osteogenesis imperfecta type V mimicking osteosacroma: 4-year follow-up with resolution. Skeletal Radiol 2006; 35: 402-5.
    Open DOISearch in Google Scholar
  18. 18. Rieker O, Kreitner KF, Karbowski A. Hyperplastic callus formation in osteogenesis imperfecta: CT and MRI findings. Eur Radiol 1998; 8: 1137-9.
    Open DOISearch in Google Scholar
  19. 19. Dobrocky I, Seidl G, Grill F. MRI and CT features of hyperplastic callus in osteogenesis imperfecta tarda. Eur Radiol 1999; 9: 665-8.
    Open DOISearch in Google Scholar
  20. 20. Cheung MS, Azouz EM, Glorieux FH, Rauch F. Hyperplastic callus formation in osteogenesis imperfecta type V: follow-up of three generations over ten years. Skeletal Radiol 2008; 37: 465-7.
    Open DOISearch in Google Scholar
  21. 21. Cho TJ, Lee KE, Lee SK, Song SJ, Kim KJ, Jeon D. et al. A single recurrent mutation in the 5’-UTR of IFITM5 causes osteogenesis imperfecta type V. Am J Hum Genet 2012; 91: 343-8.
    Open DOISearch in Google Scholar
  22. 22. Semler O, Garbes L, Keupp K, Swan D, Zimmermann K, Becker J. et al. A mutation in the 5’-UTR of IFITM5 creates an in-frame start codon and causes autosomal-dominant osteogenesis imperfecta type V with hyperplastic callus. Am J Hum Genet 2012; 91: 349-57.
    Open DOISearch in Google Scholar
  23. 23. Rauch F, Moffatt P, Cheung M, Roughley P, Lalic L, Lund AM. et al. Osteogenesis imperfecta type V: marked phenotypic variability despite the presence of the IFITM5 c.-14C>T mutation in all patients. J Med Genet 2013; 50: 21-4.
    Open DOISearch in Google Scholar
  24. 24. Shapiro JR, Lietman C, Grover M, Lu JT, Nagamani SC, Dawson BC. et al. Phenotypic variability of osteogenesis imperfecta type V caused by IFITM5 mutation. J Bone Miner Res 2013; 28: 1523-30.
    Open DOISearch in Google Scholar
  25. 25. Balasubramanian M, Parker MJ, Dalton A, Giunta C, Lindert U, Peres LC. et al. Genotype-phenotype study in type V osteogenesis imperfecta. Clin Dysmorphol 2013; 22: 93-101
    Open DOISearch in Google Scholar
  26. 26. Lamovec J, Možina E, Baebler B. Hyperplastic callus formation in osteogenesis imperfecta. Ann Diag Pathol 2003; 7: 231-5.
    Open DOISearch in Google Scholar
  27. 27. Lee DY, Cho TJ, Choi IH, Chung CY, Yoo WY, Kim JH. et al. Clinical and radiological manifestations of osteogenesis imperfecta type V. J Korean Med Sci 2006; 21: 709-14.
    Open DOISearch in Google Scholar
  28. 28. Zeitlin L, Rauch F, Travers R, Munns C, Glorieux FH. The effect of cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta Type V. Bone 2006; 38; 13-20.
    Open DOISearch in Google Scholar
  29. 29. Fleming F, Woodhead HJ, Briody JN, Hall J, Cowell CT, Ault J. et al. Cyclic bisphosphonate therapy in osteogenesis type V. J Pediatr Child Health 2005; 41: 147-51.
    Open DOISearch in Google Scholar
  30. 30. Vuorimies I, Toiviainen-Salo S, Hero M, Mäkitie O. Zoledronic acid treatment in children with osteogenesis imperfecta. Horm Res Paediatr 2011; 75: 346-53.
    Open DOISearch in Google Scholar
  31. 31. Zacharin M, Bateman J. Pamidronate treatment of osteogenesis imperfecta-lack of correlation between clinical severity, age at onset of treatment, predicted collagen mutation and treatment response. J Pediatr Endocrinol Metab 2002; 15: 163-74.
    Open DOISearch in Google Scholar
  32. 32. Marini F. Falchetti A, Silvestri S, Bagger Y, Luzi E, Tanini A. et al. Modulatory effect of farnesyl pyrophosphate synthase (FDPS) rs2297480 polymorphism on the response to long-term aminobisphosphonate treatment in postmenopausal osteoporosis. Curr Med Res Opin 2008; 24: 2609-15.
    Open DOISearch in Google Scholar
  33. 33. Choi HJ, Choi JY, Cho SW, Kang D, Han KO, Kim SW. et al. Genetic polymorphism in geranylgeranyl diphosphate synthase (GGSP1) predicts bone density response to bisphosphonate therapy in Korean women. Yonsei Med J 2010; 51: 231-8.
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.1515/sjph-2015-0018 | Journal eISSN: 1854-2476 | Journal ISSN: 0351-0026
Journal RSS Feed
Language: English, Slovenian
Page range: 119 - 125
Submitted on: Dec 16, 2014
Accepted on: Feb 3, 2015
Published on: Mar 13, 2015
Published by: National Institute of Public Health, Slovenia
In partnership with: Paradigm Publishing Services
Keywords:
bone mineral density,
hypertrophic callus,
IFITM5 gene,
bisphosphonates
Related subjects:
Medicine,
Clinical medicine,
Hygiene and environmental medicine

© 2015 Nina Bratanic, Bojana Dzodan, Katarina Trebusak Podkrajsek, Sara Bertok, Barbara Ostanek, Janja Marc, Tadej Battelino, Magdalena Avbelj Stefanija, published by National Institute of Public Health, Slovenia
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Volume 54 (2015): Issue 2 (June 2015)
Previous article
Next article